This inventor holds 1 USPTO granted patent. Top assignee: University of Utah Research Foundation. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Hongsuk Park: Innovator in Anti-Obesity Gene Constructs
Introduction
Hongsuk Park is a prominent inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of biotechnology, particularly in the development of gene constructs aimed at combating obesity. His innovative work has the potential to impact metabolic health positively.
Latest Patents
Hongsuk Park holds a patent for a groundbreaking invention titled "Combinatorial gene construct and non-viral delivery for anti-obesity." This invention provides a plasmid that comprises two or more anti-obesity genes. The patent details compositions and host cells that utilize the plasmid, along with methods for increasing metabolic activity in mammals. Specifically, the plasmid includes nucleic acid sequences encoding islet amyloid polypeptide (IAPP), leptin (LEP), and fibronectin type III domain containing 5 (FNDC5). This innovative approach offers new avenues for addressing obesity through genetic intervention.
Career Highlights
Hongsuk Park is affiliated with the University of Utah Research Foundation, where he continues to advance his research in gene therapy and metabolic health. His work is characterized by a commitment to developing effective solutions for obesity, a growing health concern worldwide.
Collaborations
Throughout his career, Hongsuk Park has collaborated with notable colleagues, including You Han Bae and Sungpil Cho. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the field.
Conclusion
Hongsuk Park's contributions to the field of biotechnology, particularly in anti-obesity gene constructs, highlight his role as a leading inventor. His patented work has the potential to revolutionize approaches to obesity treatment and improve metabolic health.